Breaking News
Get Actionable Insights with InvestingPro+: Start 7 Day FREE Trial Register here
Investing Pro 0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details
Close

NextCure  Inc (NXTC)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow NextCure's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
3.770 +0.130    +3.57%
13:54:08 - Real-time Cboe. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
ISIN:  US65343E1082 
CUSIP:  65343E108
  • Volume: 51,711
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 3.680 - 3.832
NextCure 3.770 +0.130 +3.57%
IndustryBiotechnology
SectorHealthcare
Employees

87

Equity Type

ORD

NextCure, Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing novel immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. Its lead product candidate is NC318, which is in Phase II clinical trials for the treatment of advanced or metastatic solid tumors. The company is also developing NC410, which is in Phase I for novel immunomedicine designed to block immune suppression mediated by an immune modulator called Leukocyte-Associated Immunoglobulin-like Receptor 1; NC762, an immunomedicine targeting a molecule called human B7 homolog 4 protein, or B7-H4; and NC525, a novel LAIR-1 antibody which is in Preclinical trails that targets acute myeloid leukemia, blast cells, and leukemic stem cells. Its discovery and research programs include an antibody in preclinical evaluation of other potential novel immunomodulatory molecules. The company has a license agreement with Yale University. NextCure, Inc. was incorporated in 2015 and is headquartered in Beltsville, Maryland.

Contact Information

Top Executives

Name Age Since Title
David S. Kabakoff 74 2015 Independent Chairman of the Board
Elaine V. Jones 67 2015 Independent Director
Garry A. Nicholson 67 2020 Independent Director
John G. Houston 62 2020 Independent Director
Weiping Zou - 2021 Member of Scientific Advisory Board
Ursula A. Matulonis - 2021 Member of Scientific Advisory Board
Chau Quang Khuong 46 2015 Independent Director
Stephen D. Miller - - Member of Scientific Advisory Board
Michael S. Richman 61 2015 Co-Founder, CEO, President & Director
Stephen W. Webster 61 2019 Independent Director
Mario Sznol 64 - Member of Scientific Advisory Board
Elizabeth M. Jaffee - 2021 Member of Scientific Advisory Board
Anne Elizabeth Borgman-Hagey 54 2021 Independent Director
Ellen G. Feigal 68 2021 Independent Director
Lieping Chen 64 2015 Co-Founder & Chairman of Scientific Advisory Board
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

NXTC Comments

Write your thoughts about NextCure  Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Brad Logan
Brad Logan Jul 22, 2020 9:32PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Whats the story on this company? I just bought in at $9.27. Its been hit hard but maybe due for a comeback?
Shane Hacker
Shane Hacker Nov 05, 2019 11:37AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
lol
Cookie Crumbler
Cookie Crumbler Nov 05, 2019 11:37AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
glad u r laughing ! I am LOL now, since I can buy it this cheap now
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email